You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
興科蓉醫藥(06833.HK)代理產品首次成都進口通關 縮減通關時間及物流成本
阿思達克 01-13 09:23

興科蓉醫藥(06833.HK)公布,從德國進口的1.65萬瓶、貨值近60萬美元的首批奧克特諾爾品牌人血白蛋白順利抵達成都雙流國際機場口岸,在成都海關和四川省藥品監督管理局監管下順利從完成通關。

集團表示,這是自成都口岸獲批進口生物製品指定口岸城市後,其公司代理的生物製品類產品首次選擇在成都進口通關。以往,公司進口該產品均需要繞道北上廣進口後再將產品運回成都。僅通關時間基本上就需要兩周左右。

作為一家以成都為中心,輻射全國市場的藥品批發類經營企業,週期長、效率低、成本高一直是困擾公司多年的難題。而進口生物製品成都口岸的開放,實現了公司的產品在家門口的進口通關。這次僅用了一天就完成了通關手續。這不僅極大減少了產品進口通關時間和綜合物流成本,將帶動整個成都地區生物醫藥產業的發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account